Study Reveals Regulatory Mechanisms of AMP Deaminase-2 in Fructose and Nucleotide Metabolism
Researchers have successfully expressed and purified the human liver enzyme AMPD2-2 for the first time, uncovering how it is activated and inhibited by cellular molecules including ATP, GTP, and phosphate. The enzyme sits at a critical junction in fructose metabolism, where excess fructose consumption drives a cascade that ultimately produces uric acid, a compound linked to gout, metabolic acidosis, and mitochondrial dysfunction. The findings clarify how the body normally suppresses uric acid buildup and open a path toward targeted drugs that could limit the harmful effects of high fructose intake.
A new study published on bioRxiv reports the first successful laboratory expression and purification of both the full-length and catalytic domains of human liver AMP deaminase-2 (hAMPD2-2), an enzyme central to fructose and nucleotide metabolism. Steady-state kinetic experiments showed that ATP allosterically activates the enzyme at physiological concentrations of 2–5 mM, and that this activation site appears to reside within the catalytic domain itself rather than a separate regulatory region. GTP competitively inhibits the ATP-activated enzyme with inhibition constants of 74 µM and 101 µM for the full-length and catalytic domains respectively, suggesting GTP and ATP compete at the same allosteric site. Inorganic phosphate (Pi), previously characterized as a simple competitive inhibitor in yeast AMPD, was found to play a more nuanced role in the human enzyme: rather than acting alone, Pi enhances inhibition specifically when the enzyme is already bound to GTP, further suppressing uric acid production under normal physiological conditions. Together, these regulatory mechanisms mean that uric acid accumulation is kept in check unless both GTP and Pi levels fall simultaneously, a situation that can arise during heavy fructose consumption. The authors argue that understanding this regulatory architecture provides a rational basis for designing therapeutics aimed at blocking uric acid overproduction in conditions such as gout and metabolic syndrome.
What's missing
As a preprint, this study has not yet undergone formal peer review, so its methods and conclusions have not been independently validated. The study is conducted entirely in vitro using bacterially expressed protein, so it is unclear whether the observed regulatory dynamics fully replicate the enzyme's behavior inside intact human liver cells or in vivo. The physiological conditions under which GTP and Pi levels drop sufficiently to unleash AMPD2-2 activity during fructose consumption are not quantitatively defined. No therapeutic candidates or inhibitor designs are presented, leaving the translational implications speculative at this stage.
What different sources said
- bioRxivCenter
Deciphering AMP deaminase-2 structure, activators and regulators underpinning cellular function in human fructose and nucleotide metabolism
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.